NeuroSense Therapeutics Ltd. Benefits Paid Or Payable
NeuroSense Therapeutics Ltd. (NRSN) reported Benefits Paid Or Payable of $1.01 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Cash Flow › Other Cash Flow Items
ifrs-full:BenefitsPaidOrPayable · last filed 2024-04-04
| Period end | Benefits Paid Or Payable 6 month | Benefits Paid Or Payable 6 month as first filed | Benefits Paid Or Payable 12 month | Benefits Paid Or Payable 12 month as first filed |
|---|---|---|---|---|
| 2023-12-31 | $1.01M 20-F · filed 2024-04-04 | |||
| 2023-06-30 | $700.00K 6-K · filed 2023-08-16 | |||
| 2022-12-31 | $837.00K 6-K · filed 2023-08-16 | $837.00K 20-F · filed 2024-04-04 | ||
| 2022-06-30 | $406.00K 6-K · filed 2023-08-16 | $529.00K 6-K/A · filed 2023-01-19 | ||
| 2021-12-31 | $74.00K 20-F · filed 2024-04-04 | $447.00K 20-F · filed 2022-04-14 | ||
| 2021-06-30 | $150.00K 6-K/A · filed 2023-01-19 | |||
| 2020-12-31 | $52.00K 20-F · filed 2023-03-22 | $227.00K 20-F · filed 2022-04-14 | ||
| 2019-12-31 | $105.00K 20-F · filed 2022-04-14 |